Akanda Share Holder Equity 2021-2024 | AKAN
Akanda share holder equity from 2021 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Akanda Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $-4 |
| 2022 | $27 |
| 2021 | $-2 |
| 2020 | $-5 |
| Akanda Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-4 |
| 2023-06-30 | $22 |
| 2022-12-31 | $27 |
| 2022-06-30 | $35 |
| 2021-12-31 | $-2 |
| 2020-12-31 | $-5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.002B | $0.001B |
| Akanda Corp. provides medical cannabis and wellness platform. The company's initial portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. Akanda Corp. is based in LONDON. | |||